Publications, Pharmaceutical

Microbial integrity testing for preservative-free drug formulations

Preservative-free formulation can protect patients from the adverse effects of additives and is a growing trend in eye care and nasal drug products.

This paper presents a new tip seal integrity test – TSIT 2.0 – that provides a reasonable and representative challenge for preservative-free solutions with respect to their ability to safeguard microbial integrity. The test uses three germs rather than pseudomonas aeruginosa alone and involves repeated submersion of the discharge orifice during actuation. It is simple, and test duration is relatively short with results generated over a 10-day period. Experimental data are presented to illustrate the application of the new TSIT 2.0 test to an eyedropper. The test is the culmination of a long series of experiments and the results confirm its efficacy for testing the ability of antimicrobial measures to preserve microbial integrity.

Download Publication
3 Jun 2019

Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery

Find Out More

This Might Also Be of Interest

2 May 2023

Using Intranasal Delivery for Drug Repositioning: A Compelling Proposition for Lifecy...

Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
24 Apr 2023

The Potential and Challenge of Nasal Vaccination

Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
20 Apr 2023

Exploring Systemic Nasal Delivery: Systems & Formulations

Publications, Pharmaceutical, Market Insights, Product Solutions, Device Innovations, Brand Differentiation

Read More
27 Mar 2023

Delivery of Biologics to the Nasal Cavity: The Future of Nasal Drug Delivery

Webinars, Pharmaceutical, Market Insights, Product Solutions, Device Innovations

Read More
1 6 7 8 9 10 29
Back To Top